Irinotecan 300 mg for intravenous injections MEDAC Germany
Article:
M-7
In Stock
Interchangeable drugs with the same active ingredient:
- Vizirin
- Irin
- Irin-Health
- Irinoval
- Irinosindan
- Irinotecan "Ebewe"
- Irinotecan Amaxa
- Irinotecan Medac
- Irinotecan Main
- Irinotecan-Vista
- Irinotecan-Tewa
- Iriten
- Irnokam
- Kumpter
- Campto
- Camptothecan
- Strinotek
- Ertikan
Indications
Treatment of patients with advanced colorectal cancer:
- In combination with 5-fluorouracil and folic acid in patients who have not received prior chemotherapy for advanced disease;
- As monotherapy in patients who have established a treatment regimen with the use of 5-fluorouracil was ineffective.
- In combination with cetuximab, Irinotecan Ebewe can be used to treat metastatic colorectal cancer with wild-type KRAS expressing epidermal growth factor receptors in patients who have not previously received treatment for metastatic cancer or for whom cytotoxic treatment with irinotecan has failed.
- In combination with 5-fluorouracil, folic acid and bevacizumab, Irinotecan "Ebewe" should be used as first-line therapy in patients with metastatic carcinomas of the colon or rectum.
- In combination with capecitabine (with or without the addition of bevacizumab), Irinotecan Ebewe should be used as first-line therapy in patients with metastatic colorectal cancer971772267;27
-
Commercial name:Irinotecan
-
Dosage:100 mg
-
Release form:Bottle
-
Производитель:Турция
No reviews yet